Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Yкраїнський (UK)
Przejdź do strony domowej biblioteki Centralna Biblioteka Wojskowa Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaCentralna Biblioteka Wojskowa

Wyszukujesz frazę "Pharmaceutical industry" wg kryterium: Temat

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-7 z 7
    Tytuł:
    Etyczne wyzwania współpracy pomiędzy lekarzami a przemysłem farmaceutycznym
    Autorzy:
    Makowska, Marta
    Powiązania:
    https://bibliotekanauki.pl/articles/653060.pdf
    Data publikacji:
    2011
    Wydawca:
    Uniwersytet Łódzki. Wydawnictwo Uniwersytetu Łódzkiego
    Tematy:
    physicians
    pharmaceutical industry
    business ethics
    Źródło:
    Annales. Etyka w Życiu Gospodarczym; 2011, 14, 2
    1899-2226
    2353-4869
    Pojawia się w:
    Annales. Etyka w Życiu Gospodarczym
    Dostawca treści:
    Biblioteka Nauki
    Artykuł
    Tytuł:
    Controversial advertising of medicines. A comparison between Poland and the United States
    Autorzy:
    Makowska, Marta
    Powiązania:
    https://bibliotekanauki.pl/articles/653027.pdf
    Data publikacji:
    2018
    Wydawca:
    Uniwersytet Łódzki. Wydawnictwo Uniwersytetu Łódzkiego
    Tematy:
    pharmaceutical industry
    advertisement
    drugs
    law
    ethics
    Opis:
    For many years, the subject of aggressive marketing campaigns conducted by pharmaceutical companies has been raised in Poland. Drug ads are everywhere, on television, the radio, magazines and on the Internet. Therefore, it is extremely important is to ensure both their legal and ethical dimension. This article will present the differences between direct-to-consumer advertising of medicines in Poland and in the US. The dissimilarities result mainly from differences in legislation. In Poland, the law is much stricter than in the US. For example, in the United States companies are allowed to advertise prescription drugs directly to patients. In the whole of the European Union, and thus in Poland, it is strictly prohibited. The article will also present other regulations existing in Poland and in the United States and it will compare them. It will offer examples of violations of the law and ethics in the advertising of medicine in both countries. Lastly, it will briefly outline the negative consequences of unacceptable pharmaceutical marketing.
    Źródło:
    Annales. Etyka w Życiu Gospodarczym; 2018, 21, 5; 67-79
    1899-2226
    2353-4869
    Pojawia się w:
    Annales. Etyka w Życiu Gospodarczym
    Dostawca treści:
    Biblioteka Nauki
    Artykuł
    Tytuł:
    Etyczne wyzwania w przemyśle farmaceutycznym. Zarys problematyki
    Ethical Challenges in the Pharmaceutical Industry. An Outline of Issues
    Autorzy:
    Kaczmarek, Emilia
    Powiązania:
    https://bibliotekanauki.pl/articles/965064.pdf
    Data publikacji:
    2015-09
    Wydawca:
    Uniwersytet Łódzki. Wydawnictwo Uniwersytetu Łódzkiego
    Tematy:
    pharmaceutical industry
    bioethics
    conflict of interests
    pharmaceuticalization
    Opis:
    The goal of the text is to show which actions of the modern pharmaceutical industry are morally controversial. There are several burning issues that we need to face on this field, such as: How to deal with the conflict of interests within the medicine? How to mark the vanishing boundaries between information and advertisement concerning the pharmaceutical education? How does the drug advertisement lead to the pharmaceuticalization of society? In the text all of these problems will be briefly analysed. The article has an introductory character, it may serve as an overview of the burning issues in the pharmaceutical industry ethics – all questions that are posed in the text need further examination.
    Źródło:
    Annales. Etyka w Życiu Gospodarczym; 2015, 18, 3
    1899-2226
    2353-4869
    Pojawia się w:
    Annales. Etyka w Życiu Gospodarczym
    Dostawca treści:
    Biblioteka Nauki
    Artykuł
    Tytuł:
    Znaczenie „przejrzystości” w relacjach lekarzy z firmami farmaceutycznymi
    The Importance of ‘Disclosure’ in Relationships between Physicians and Pharmaceutical Companies
    Autorzy:
    Makowska, Marta
    Jasiński, Łukasz
    Powiązania:
    https://bibliotekanauki.pl/articles/653000.pdf
    Data publikacji:
    2017
    Wydawca:
    Uniwersytet Łódzki. Wydawnictwo Uniwersytetu Łódzkiego
    Tematy:
    -
    conflict of interest
    disclosure
    ethical standard
    pharmaceutical industry
    Opis:
    The article raises issues of transparency in relationships between doctors and drug manufacturers. It indicates how important it is as a way for physicians and the pharmaceutical industry to regain public trust. The manuscript will define the concept of disclosure. It will discuss in detail The Physician Payment Sunshine Act from the U.S., which imposes a legal obligation on pharmaceutical companies to disclose their relationships with doctors and university hospitals. The article will also show the diverse regulation of disclosure in different countries of the European Union. The situation in Poland will be also described. In the summary, there will be a discussion about the importance of disclosure for patients and the advantages and disadvantages of such regulations for physicians and drug manufacturers.
    -
    Źródło:
    Annales. Etyka w Życiu Gospodarczym; 2017, 20, 1
    1899-2226
    2353-4869
    Pojawia się w:
    Annales. Etyka w Życiu Gospodarczym
    Dostawca treści:
    Biblioteka Nauki
    Artykuł
    Tytuł:
    The importance of “disclosure” in relationships between physicians and pharmaceutical companies
    Autorzy:
    Makowska, Marta
    Jasiński, Łukasz
    Powiązania:
    https://bibliotekanauki.pl/articles/653029.pdf
    Data publikacji:
    2018
    Wydawca:
    Uniwersytet Łódzki. Wydawnictwo Uniwersytetu Łódzkiego
    Tematy:
    conflict of interest
    disclosure
    ethical standard
    pharmaceutical industry
    Opis:
    The article raises issues of transparency in relationships between doctors and drug manufacturers. It indicates how important it is as a way for physicians and the pharmaceutical industry to regain public trust. The manuscript will define the concept of disclosure. It will discuss in detail The Physician Payment Sunshine Act from the U.S., which imposes a legal obligation on pharmaceutical companies to disclose their relationships with doctors and university hospitals. The article will also show the diverse regulation of disclosure in different countries of the European Union. The situation in Poland will be also described. In the summary, there will be a discussion about the importance of disclosure for patients and the advantages and disadvantages of such regulations for physicians and drug manufacturers.
    Źródło:
    Annales. Etyka w Życiu Gospodarczym; 2018, 21, 5; 81-94
    1899-2226
    2353-4869
    Pojawia się w:
    Annales. Etyka w Życiu Gospodarczym
    Dostawca treści:
    Biblioteka Nauki
    Artykuł
    Tytuł:
    Etyczne uregulowania kontaktów studentów medycyny z firmami farmaceutycznymi w Stanach Zjednoczonych
    Ethical Regulation of Medical Students’ Interactions with the Pharmaceutical Industry in the United States
    Autorzy:
    Makowska, Marta
    Powiązania:
    https://bibliotekanauki.pl/articles/20311662.pdf
    Data publikacji:
    2014
    Wydawca:
    Uniwersytet Łódzki. Wydawnictwo Uniwersytetu Łódzkiego
    Tematy:
    pharmaceutical industry
    medical education
    conflict-of-intrest policies
    business ethics
    Opis:
    The involvement of the pharmaceutical industry in medical education can be seen as something completely natural. Who better than the producer of the med-icine would know how the drug was developed, how the process of it being au-thorized for sale proceeded, and what the side effects of it are? Today in the United States, more and more colleges are implementing strong pharmaceutical conflict-of-interest policies. Interaction between students and medical school staff with these companies is undesirable, because they share marketing materi-als more often than honest data, and their representatives use various ways to influence these current and future physicians during their meetings. This article will describe research which shows what pharmaceutical mar-keting directed at students looks like in the USA – its character, frequency, and potential impact on future medical decisions. Also, ways of regulating interac-tion between medical schools, their staff and students and the pharmaceutical industry will be expressed. Guidelines of the Association of American Medical Colleges, the Institute of Medicine and the American Medical Student Associa-tion will be described. At the end, questions about their influence on reality and whether medical schools’ policies can be an effective barrier for pharmaceutical marketing on medical schools will be asked.
    Źródło:
    Annales. Etyka w Życiu Gospodarczym; 2014, 17, 3; 125-137
    1899-2226
    2353-4869
    Pojawia się w:
    Annales. Etyka w Życiu Gospodarczym
    Dostawca treści:
    Biblioteka Nauki
    Artykuł
    Tytuł:
    Kontrowersje związane z reklamowaniem leków Analiza porównawcza Polski i Stanów Zjednoczonych
    Controversial Advertising of Medicines. A Comparison between Poland and the United States
    Autorzy:
    Makowska, Marta
    Powiązania:
    https://bibliotekanauki.pl/articles/965175.pdf
    Data publikacji:
    2016-09-15
    Wydawca:
    Uniwersytet Łódzki. Wydawnictwo Uniwersytetu Łódzkiego
    Tematy:
    pharmaceutical industry
    advertisement
    drugs
    law
    ethics
    I18
    M31
    M38
    Opis:
    For many years, the subject of aggressive marketing campaigns conducted by pharmaceutical companies has been raised in Poland. Drug ads are everywhere, on television, the radio, magazines and on the Internet. Therefore, it is extremely important is to ensure both their legal and ethical dimension. In my article I will present the differences between direct-to-consumer advertising of medicines in Poland and in the US. The dissimilarities result mainly from differences in legislation. In Poland the law is much stricter than in the US. For example, in the United States companies are allowed to advertise prescription drugs directly to patients. In the whole of the European Union, and thus in Poland, it is strictly prohibited. The article will present other regulations existing in Poland and in the United States and it will compare them. It will show examples of violations of the law and ethics in the advertising of medicine in both countries. It will briefly outline the negative consequences of unacceptable pharmaceutical marketing.
    Źródło:
    Annales. Etyka w Życiu Gospodarczym; 2016, 19, 3
    1899-2226
    2353-4869
    Pojawia się w:
    Annales. Etyka w Życiu Gospodarczym
    Dostawca treści:
    Biblioteka Nauki
    Artykuł
      Wyświetlanie 1-7 z 7

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies